SOPHIM announces the acquisition of Novastell, a leading supplier of nutritional and
functional ingredients. The transaction, finalized in September 2023, led to an official
presentation of the teams in Peyruis, in the south of France, in early 2024.
SOPHIM’s acquisition of Novastell represents a strategic move aimed at furthering the
company’s expansion. With a strong presence in the cosmetics and pharmaceutical sectors,
SOPHIM is pursuing its growth with this acquisition. A merger marking a new stage in
SOPHIM’s diversification. Through this integration, SOPHIM raises its consolidated sales for
2023 to 36 million euros, with a total workforce of 80, while asserting its status as an
integrated and autonomous player.
“Synergies between cosmetics and nutraceuticals are increasingly numerous. This acquisition
will enable us to accelerate our growth and bring new products to market more quickly” says
Jacques Margnat, Chairman and CEO of SOPHIM.
“This acquisition is of particular importance given the convergence of our business models:
Novastell, as Sophim, valorizes byproducts from the oil industry to create ingredients for the
nutraceutical industry. This match not only reflects our shared values, but also responds to
market dynamics, reinforcing the strategic relevance of our merger” adds Alexis Margnat,
Managing Director of SOPHIM.
